Journal of Global Infectious DiseasesOfficial Publishing of INDUSEM and OPUS 12 Foundation, Inc. Users online:1367  
Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size     
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
 
This article has been cited by
1QSAR based therapeutic management of M. tuberculosis
Shahzaib Ahamad,Safikur Rahman,Faez Iqbal Khan,Neeraja Dwivedi,Sher Ali,Jihoe Kim,Md. Imtaiyaz Hassan
Archives of Pharmacal Research.2017;40(6)676
[DOI]
2The internal gene duplication and interrupted coding sequences in the MmpL genes of Mycobacterium tuberculosis: Towards understanding the multidrug transport in an evolutionary perspective
Padmani Sandhu,Yusuf Akhter
International Journal of Medical Microbiology.2015;305(3)413
[DOI]
3Analysis of CTLA-4 (+49A/G) Gene Polymorphism and the Risk of Tuberculosis in Southeast of Iran
Edris Paad,Mohammad Kordi Tamendani,Mohammad Hosain Sangtarash,Mansoor Dehvari
Gene, Cell and Tissue.2014;1(3)413
[DOI]
4Encapsulation of zinc-rifampicin complex into transferrin-conjugated silver quantum-dots improves its antimycobacterial activity and stability and facilitates drug delivery into macrophages
Rashmirekha Pati,Rojalin Sahu,Jagannath Panda,Avinash Sonawane
Scientific Reports.2016;6(1)413
[DOI]
5Platinum(II)-azoimidazole drugs against TB and cancer: Structural studies, cytotoxicity and anti-mycobacterial activity
Chandana Sen,Chiranjit Patra,Sudipa Mondol,Amitabha Datta,Debashis Mallick,Tapan Kumar Mondal,Tulin Askun,Pinar Celikboyun,Zerrin Cantürk,Chittaranjan Sinha
Polyhedron.2018;152(1)1
[DOI]
6Use of classification and regression tree (CART), to identify hemoglobin A1C (HbA 1C ) cut-off thresholds predictive of poor tuberculosis treatment outcomes and associated risk factors
Josephine W. Mburu,Leonard Kingwara,Magiri Ester,Nyerere Andrew
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases.2018;11(1)10
[DOI]
7Inhalable liposomes of Glycyrrhiza glabra extract for use in tuberculosis: formulation, in vitro characterization, in vivo lung deposition, and in vivo pharmacodynamic studies
Vivek Viswanathan,Rajesh Pharande,Anilkumar Bannalikar,Pushpa Gupta,Umesh Gupta,Alka Mukne
Drug Development and Industrial Pharmacy.2019;45(1)11
[DOI]
8Inhalable liposomes of Glycyrrhiza glabra extract for use in tuberculosis: formulation, in vitro characterization, in vivo lung deposition, and in vivo pharmacodynamic studies
Agnieszka M. Frydrych,Camile S. Farah
Drug Development and Industrial Pharmacy.2018;45(1)1
[DOI]
9Health-related quality of life among tuberculosis patients under Revised National Tuberculosis Control Programme in rural and urban Puducherry
S. Ramkumar,S. Vijayalakshmi,N. Seetharaman,R. Pajanivel,A. Lokeshmaran
Indian Journal of Tuberculosis.2017;64(1)14
[DOI]
10Endothelial lineage-specific interaction of Mycobacterium tuberculosis with the blood and lymphatic systems
Paul M. Kim,Jae-Jin Lee,Dongwon Choi,Hyungjin Eoh,Young-Kwon Hong
Tuberculosis.2018;111(1)1
[DOI]
11Burgeoning double burden of tuberculosis and diabetes in India: Magnitude of the problem – Strategies and solutions
Preety Sharma,Fehmida Visnegarwala,Vinay Tripathi
Clinical Epidemiology and Global Health.2014;2(3)107
[DOI]
12Drug development against tuberculosis: Impact of alkaloids
Shardendu K. Mishra,Garima Tripathi,Navneet Kishore,Rakesh K. Singh,Archana Singh,Vinod K. Tiwari
European Journal of Medicinal Chemistry.2017;137(3)504
[DOI]
13SMS reminders to improve adherence and cure of tuberculosis patients in Cameroon (TB-SMS Cameroon): a randomised controlled trial
Georges Bediang,Beat Stoll,Nadia Elia,Jean-Louis Abena,Antoine Geissbuhler
BMC Public Health.2018;18(1)504
[DOI]
14Clinical and Molecular Risk Factors of Anti-tubercular Therapy Induced Hepatitis
Premashis Kar,Rahul Karna,Rajesh Ruttala,Shilpa Arora,Anita Chakravarty,Suresh Kumar
Journal of Clinical and Experimental Hepatology.2019;9(2)200
[DOI]
15Gene silencing by CRISPR interference in mycobacteria
Eira Choudhary,Preeti Thakur,Madhu Pareek,Nisheeth Agarwal
Nature Communications.2015;6(1)200
[DOI]
16Prevalencia de la sintomatología respiratoria en trabajadores mineros del municipio de Socotá, Boyacá, 2017
Nelson Camilo Gutiérrez-Alvarado
Revista Investigación en Salud Universidad de Boyacá.2018;5(1)99
[DOI]
17Molecular detection of Mycobacterium tuberculosis in cattle and buffaloes: a cause for public health concern
Khaled A. Abdel-Moein,Osman Hamed,Heba Fouad
Tropical Animal Health and Production.2016;48(8)1541
[DOI]
18Incidence of mycobacterial disorders in Indian adult male service population followed for over two decades
Hari K.V.S. Kumar,Saroj K. Patnaik
Journal of Infection and Public Health.2018;11(4)581
[DOI]
19Incidence of mycobacterial disorders in Indian adult male service population followed for over two decades
Agnieszka M. Frydrych,Camile S. Farah
Journal of Infection and Public Health.2019;11(4)871
[DOI]
20Direct detection of rpoB and katG gene mutations of Mycobacterium tuberculosis in clinical samples
Sunil Pandey,Ashima Lamichhane,Anu Byanjankar,Ansuma Kharel,Chandrakala Rai,Sunil Prasad Lekhak,Menuka Karki
Asian Pacific Journal of Tropical Biomedicine.2017;7(8)698
[DOI]
21Novel TetR family transcriptional factor regulates expression of multiple transport-related genes and affects rifampicin resistance in Mycobacterium smegmatis
Huicong Liu,Min Yang,Zheng-Guo He
Scientific Reports.2016;6(1)698
[DOI]
22Evaluation of pyrosequencing for extensive drug resistance-defining anti-tuberculosis drugs for use in public healthcare
Remya Nambiar,Daksha Shah,Kanchan Ajbani,Mubin Kazi,Meeta Sadani,Anjali Shetty,Padmaja Keskar,Sanjeev Kamble,Alex van Belkum,Camilla Rodrigues
Tuberculosis.2018;110(1)86
[DOI]
23Prevalence and detection of drug resistant mutations in Mycobacterium tuberculosis among drug naïve patients in Nairobi, Kenya
Collins Otieno Ogari,Anthony Kebira Nyamache,James Nonoh,Evans Amukoye
BMC Infectious Diseases.2019;19(1)86
[DOI]
24Pharmacovigilance and Public Health Ethics
Torbjörn Callréus
Pharmaceutical Medicine.2013;27(3)157
[DOI]
25Sulfonamide derivatives as Mycobacterium tuberculosis inhibitors: in silico approach
Sayantan Pradhan,Chittaranjan Sinha
In Silico Pharmacology.2018;6(1)157
[DOI]
26Molecular Epidemiology of Mycobacteriosis in Wildlife and Pet Animals
Mark D. Schrenzel
Veterinary Clinics of North America: Exotic Animal Practice.2012;15(1)1
[DOI]
27The implementation of Xpert MTB/RIF assay for diagnosis of tuberculosis in Nepal: A mixed-methods analysis
Basant Joshi,Trisasi Lestari,Stephen Michael Graham,Sushil Chandra Baral,Sharat Chandra Verma,Gokarna Ghimire,Bandana Bhatta,Shyam Prakash Dumre,Adi Utarini,Seyed Ehtesham Hasnain
PLOS ONE.2018;13(8)e0201731
[DOI]
28Vernonia adoensis Leaf Extracts Cause Cellular Membrane Disruption and Nucleic Acid Leakage in Mycobacterium smegmatis
Ruvimbo Mautsa,Stanley Mukanganyama
Journal of Biologically Active Products from Nature.2017;7(2)140
[DOI]
29SMS reminders to improve the tuberculosis cure rate in developing countries (TB-SMS Cameroon): a protocol of a randomised control study
Georges Bediang,Beat Stoll,Nadia Elia,Jean-Louis Abena,Désiré Nolna,Philippe Chastonay,Antoine Geissbuhler
Trials.2014;15(1)140
[DOI]
30Anti-mycobacterial activity of labdane and halimane diterpenes obtained from Plectranthus ornatus Codd
Joana M. Andrade,Alessandra Romagnoli,Joana F. Almeida,Inês M. Ferreira,Catarina Garcia,Ana Díaz-Lanza,Gian Maria Fimia,Patrícia Rijo
Journal Biomedical and Biopharmaceutical Research.2018;15(1)101
[DOI]
31Chewing the fat: lipid metabolism and homeostasis during M. tuberculosis infection
Rustin R Lovewell,Christopher M Sassetti,Brian C VanderVen
Current Opinion in Microbiology.2016;29(1)30
[DOI]
32Doctors' compliance with national guidelines and clinical pathway on the treatment of tuberculosis inpatients in Hubei, China
Xiaofei Zheng,Fangying Zhong,Xinping Zhang
Journal of Evaluation in Clinical Practice.2014;20(3)288
[DOI]
33Studies on new substituted pyridazinones: synthesis and biological evaluation
Mohammad Asif,Anita Singh,Shah Alam Khan,Asif Husain
Brazilian Journal of Pharmaceutical Sciences.2018;54(3)288
[DOI]
34The Clean India Mission: Public and animal health benefits
Rashmi Thakur,Balbir Bagicha Singh,Prateek Jindal,Rabinder Singh Aulakh,Jatinder Paul Singh Gill
Acta Tropica.2018;186(3)5
[DOI]
35Benzothiazol Clubbed Imidazol-4-ones as Anti-fungal, Anti-tubercular and Anti-HIV-1 Agents: Their Synthesis and Molecular Docking Study
Navin B. Patel,Asif R. Shaikh,Vatsal M. Patel,Edgar E. Lara-Ramirez,Gildardo Rivera
Letters in Drug Design & Discovery.2019;16(4)382
[DOI]
36Gene dose effect of NAT2 variants on the pharmacokinetics of isoniazid and acetylisoniazid in healthy Chinese subjects
Chen Bing,Cao Xiaomeia,Li Jinhenga
Drug Metabolism and Drug Interactions.2011;26(3)382
[DOI]
37Pulmonary resection for patients with multidrug-resistant tuberculosis based on survival outcomes: a systematic review and meta-analysis
Hyunsuk Frank Roh,Jihoon Kim,Seung Hyuk Nam,Jung Mogg Kim
European Journal of Cardio-Thoracic Surgery.2017;52(4)673
[DOI]
38Bactericidal Potency and Extended Serum Life of Stereo-Chemically Engineered Peptides Against Mycobacterium
Prakash Kishore Hazam,Anjali Singh,Nitin Chaudhary,Vibin Ramakrishnan
International Journal of Peptide Research and Therapeutics.2019;25(2)465
[DOI]
39Nanotechnology based anti-infectives to fight microbial intrusions
M. Rai,A.P. Ingle,S. Gaikwad,I. Gupta,A. Gade,S. Silvério da Silva
Journal of Applied Microbiology.2016;120(3)527
[DOI]
40Nanotechnology based anti-infectives to fight microbial intrusions
Agnieszka M. Frydrych,Camile S. Farah
Journal of Applied Microbiology.2018;120(3)1
[DOI]
41Risk Factors of Tuberculosis Infection Among HIV/AIDS Patients in Burkina Faso
Ziemlé Clément Méda,Issiaka Sombié,Olivier W.C. Sanon,Daouda Maré,Donald E. Morisky,Yi-Ming Arthur Chen
AIDS Research and Human Retroviruses.2013;29(7)1045
[DOI]
42Prediction of Antitubercular Peptides From Sequence Information Using Ensemble Classifier and Hybrid Features
Salman Sadullah Usmani,Sherry Bhalla,Gajendra P. S. Raghava
Frontiers in Pharmacology.2018;9(7)1045
[DOI]
43Treatment of Tuberculosis using Ethno-medicinal Plants of Amarkantak Region
Ram Sewak Kach,Vikas Kumar Sake,Poonam Sharma,Pranveer Singh
Asian Journal of Animal and Veterinary Advances.2017;13(1)52
[DOI]
  Addresses 
  My Preferences 


JGID
JGID
What's new
Forthcoming Symposia
Submit articles
Email alerts
Join us
Most popular articles
Recommend this journal
Sitemap | What's New | Feedback | Copyright and Disclaimer | Contact Us
© 2008 Journal of Global Infectious Diseases | Published by Wolters Kluwer - Medknow
Online since 10th December, 2008